COOKIES ON THE HYND HEALTHCARE WEBSITE

Meet Sarah Hynd

Sarah trained as a radiotherapy radiographer at the Middlesex Hospital and achieved her DCR(T) qualification in 1986. She has worked in clinical and managerial posts within the NHS and independent sector for over thirty years.

Her career began as a clinical radiographer at the Middlesex Hospital, later establishing the pre-treatment service at the newly formed Harley Street Clinic in the late nineties. From 2003 to 2007 she served as Head of Radiotherapy Services at UCLH, a role that included relocating an entire hospital to a new site. During her eight years with Cancer Partners UK (now GenesisCare) from 2007 to 2015 as Head of Radiotherapy, she played a key part in setting up and running eight one-linac departments across the UK, the later ones based in standalone medical centres. In early 2016 she also took a short fixed-term post as Head of Cancer Services for Spire Healthcare.

Thus she has supported the builds and moves of many new healthcare initiatives as well as fully comprehending all aspects of delivering world-class radiotherapy services where patients are at the centre. Her core skills may be applied to any service provider in addition to her expert knowledge in the field of radiotherapy. She set up her own business, Hynd Healthcare Ltd in November 2015 after leaving GenesisCare. During this time she has worked for some high profile clients. She is also a specialist advisor for the Care Quality Commission (CQC)

Meet Duncan Hynd

Duncan qualified as a radiographer at The Middlesex Hospital in 1982 and worked clinically in radiotherapy eventually starting Duncan Hynd Associates Limited (DHA) in 1995 after 10 successful years working in the industry.

DHA led the way in Europe, introducing the first CT virtual simulation systems, 3D treatment planning and prostate seed implant services, while also serving as a successful representative office, agent and distributor for many leading European and North American radiation oncology and radiotherapy companies.

DHA added considerable value to its shareholders and customers investment by creating and continuing to develop niche products and services for the Radiotherapy and Medical Imaging fields. In 2001 DHA raised £500,000 in venture capital from OTVCT and others. In 2003 the company successfully launched the range of DIB shielding doors in the UK with many blue-chip clients such as the NHS and the British Museum.

In 2013 Duncan founded Oncotherapy Resources Ltd, a start-up that provided the UK's first mobile, managed radiotherapy service. The company used the latest electronic brachytherapy systems to deliver SD-IORT, or single-dose intra-operative radiotherapy, for early-stage breast cancer during surgery.